BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
6622 results:

  • 1. Ultrasound-guided stellate ganglion block benefits the postoperative recovery of patients undergoing laparoscopic colorectal surgery: a single-center, double-blinded, randomized controlled clinical trial.
    Lu DH; Xu XX; Zhou R; Wang C; Lan LT; Yang XY; Feng X
    BMC Anesthesiol; 2024 Apr; 24(1):137. PubMed ID: 38600490
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?
    Agatsuma N; Utsumi T; Nishikawa Y; Horimatsu T; Seta T; Yamashita Y; Tanaka Y; Inoue T; Nakanishi Y; Shimizu T; Ohno M; Fukushima A; Nakayama T; Seno H
    World J Gastroenterol; 2024 Mar; 30(10):1368-1376. PubMed ID: 38596494
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Expression of immune checkpoints PD-L1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
    Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
    Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy for overweight colon cancer patients: a case-control study.
    Zhou D; Su J; Yang X; Huang L; Zheng Z; Wei H; Fang J
    Langenbecks Arch Surg; 2024 Apr; 409(1):112. PubMed ID: 38587671
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A cross-sectional study of sleep disturbance among middle-aged cancer patients at Vietnam National cancer Hospital.
    Pham AT; Do MT; Tran HTT
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2055. PubMed ID: 38577715
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mismatch repair protein deficiency and its implications on distant metastasis in colorectal cancer: A comprehensive analysis.
    Fan C; Fang C; Wang W; Lv Z; Zhang X; Long F; Jiang Z; Li Y; Zhang H; Zhou ZG; Wang C; Sun XF
    Cancer Med; 2024 Apr; 13(7):e6994. PubMed ID: 38545852
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Strassmann V; Wexner SD
    Int J Colorectal Dis; 2024 Mar; 39(1):43. PubMed ID: 38538931
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
    Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
    J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Silver nanoparticles stimulate 5-Fluorouracil-induced colorectal cancer cells to kill through the upregulation TRPV1-mediated calcium signaling pathways.
    Kaya MM
    Cell Biol Int; 2024 May; 48(5):712-725. PubMed ID: 38499507
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cardiovascular/anti-inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta-analysis of randomized trials.
    Benjamin DJ; Haslam A; Prasad V
    Cancer Med; 2024 Mar; 13(5):e7049. PubMed ID: 38491813
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial.
    Lenz HJ; Parikh A; Spigel DR; Cohn AL; Yoshino T; Kochenderfer M; Elez E; Shao SH; Deming D; Holdridge R; Larson T; Chen E; Mahipal A; Ucar A; Cullen D; Baskin-Bey E; Kang T; Hammell AB; Yao J; Tabernero J
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38485190
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The choice of diagnostic modality influences the proportion of low muscle strength, low muscle mass, and sarcopenia in colorectal cancer patients.
    Berg HB; Alavi DT; Beichmann B; Pesonen M; Henriksen C; Paur I; Bøhn SK; Lauritzen PM; Blomhoff R; Henriksen HB
    Clin Nutr ESPEN; 2024 Apr; 60():17-23. PubMed ID: 38479906
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Next-Generation Multitarget Stool DNA Test for colorectal cancer Screening.
    Imperiale TF; Porter K; Zella J; Gagrat ZD; Olson MC; Statz S; Garces J; Lavin PT; Aguilar H; Brinberg D; Berkelhammer C; Kisiel JB; Limburg PJ;
    N Engl J Med; 2024 Mar; 390(11):984-993. PubMed ID: 38477986
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Cell-free DNA Blood-Based Test for colorectal cancer Screening.
    Chung DC; Gray DM; Singh H; Issaka RB; Raymond VM; Eagle C; Hu S; Chudova DI; Talasaz A; Greenson JK; Sinicrope FA; Gupta S; Grady WM
    N Engl J Med; 2024 Mar; 390(11):973-983. PubMed ID: 38477985
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.
    Yan H; Song L; Li Y; Xu Q; Guo W; Lin S; Jiang W; Wang Z; Deng L; Huang Z; Qin H; Zhang X; Tong F; Zhang R; Liu Z; Zhang L; Yu J; Dong X; Gong Q; Deng J; Chen X; Wang J; Zhang G; Yang N; Zhang Y; Zeng L
    Cancer Immunol Immunother; 2024 Mar; 73(4):74. PubMed ID: 38451314
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Complexity of surgery and treatment burden in patients with peritoneal malignancy is not determined by addition of hyperthermic intraperitoneal chemotherapy.
    Steffens D; Ansari N; Koh C; Ahmadi N; Solomon MJ; Hogan S; Karunaratne S; Anderson T; Harvey K; McBride K; Moran B
    ANZ J Surg; 2024 Apr; 94(4):628-633. PubMed ID: 38450829
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A proteomic classifier panel for early screening of colorectal cancer: a case control study.
    Hua H; Wang T; Pan L; Du X; Xia T; Fa Z; Gu L; Gao F; Yu C; Gao F; Liao L; Shen Z
    J Transl Med; 2024 Feb; 22(1):188. PubMed ID: 38383428
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency.
    Makino K; Ishii T; Takeda H; Saito Y; Fujiwara Y; Fujimoto M; Ito T; Wakama S; Kumagai K; Munekage F; Horie H; Tomofuji K; Oshima Y; Uebayashi EY; Kawai T; Ogiso S; Fukumitsu K; Takai A; Seno H; Hatano E
    J Pathol; 2024 May; 263(1):32-46. PubMed ID: 38362598
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.
    Arai H; Yang Y; Baca Y; Millstein J; Denda T; Ou FS; Innocenti F; Takeda H; Kubota Y; Doi A; Horie Y; Umemoto K; Izawa N; Wang J; Battaglin F; Jayachandran P; Algaze S; Soni S; Zhang W; Goldberg RM; Hall MJ; Scott AJ; Hwang JJ; Lou E; Weinberg BA; Marshall J; Goel S; Xiu J; Michael Korn W; Venook AP; Sunakawa Y; Lenz HJ
    Eur J Cancer; 2024 Apr; 201():113914. PubMed ID: 38359495
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Synergic actions of botulinum neurotoxin A and oxaliplatin on colorectal tumour cell death through the upregulation of TRPM2 channel-mediated oxidative stress.
    Demir S; Duman İ; Nazıroğlu M
    Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13844. PubMed ID: 38350599
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 332.